IMPACT OF TUMOR MOLECULAR PHENOTYPE ON SURVIVAL OF PATIENTS WITH GASTRIC CANCER AFTER RADICAL SURGERY
The strategy for the treatment of gastric cancer (GC), in particular the use of the extended surgical interventions in different countries varies. The different proportion of specific molecular GC subtypes in various populations frequently is not taken into account for comparing treatment outcomes....
Gespeichert in:
| Veröffentlicht in: | Experimental oncology 2022-12, Vol.44 (4), p.324-326 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 326 |
|---|---|
| container_issue | 4 |
| container_start_page | 324 |
| container_title | Experimental oncology |
| container_volume | 44 |
| creator | Dumanskyi, Yu V Kirkilevskyi, S I Sulaeva, O M Polyasnyi, V O Mashukov, A O Kovalevska, L A Yarema, R R Ogorchak, M A |
| description | The strategy for the treatment of gastric cancer (GC), in particular the use of the extended surgical interventions in different countries varies. The different proportion of specific molecular GC subtypes in various populations frequently is not taken into account for comparing treatment outcomes. This pilot study analyzes the association of survival of GC patients after the extended combined surgical interventions depending on the molecular subtype of the tumors. An improved survival for patients with diffuse cancer types (p53-, VEGFR
, HER2/neu
, Ki-67
phenotype) was demonstrated. The authors propose their point of view on the importance of recognizing GC molecular heterogeneity.Key Words: gastric cancer, molecular classification, tumor biology. |
| doi_str_mv | 10.32471/exp-oncology.2312-8852.vol-44-no-4.18903 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2779350830</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2779350830</sourcerecordid><originalsourceid>FETCH-LOGICAL-c192t-e06457174af5d3ec8a7690a26b36eb407b7ffd7d51616d1139a0093bac05c9573</originalsourceid><addsrcrecordid>eNo9kNtOwkAQhjdGI4i-gtlLb4q73VP3sqkFmgAlZcFwtelhazCFxVaMvr3leDMzyXzzT_IBgDHqE5cK_Gp-d47d5rayH399l2DX8Tzm9n9s5VDqbK1D-9iTiNyA7nV7C7rYa2fpctkBD03ziRBnktN70CHcw5hR2gUmmsz8QMF4ANViEidwEo_DYDH2EzgbhdNYrWYhjKdwvkiW0dIfH8CZr6JwqubwPVIjOPTnKokCGPjTIEygP1BtTfy3KGjp9mwYJqtHcFemVWOezr0HFoNQBSNnHA8PnJNj6X47BnHKBBY0LVlBTO6lgkuUujwj3GQUiUyUZSEKhjnmBcZEpghJkqU5YrlkgvTAyyl3V9uvvWm-9Wbd5Kaq0q2x-0a7QkjCkEdQi0YnNK9t09Sm1Lt6vUnrP42RPlrXrXV9sa4PXvXBq26ta0r11mqqj9bbrOfz2322McU16aKZ_ANR530s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2779350830</pqid></control><display><type>article</type><title>IMPACT OF TUMOR MOLECULAR PHENOTYPE ON SURVIVAL OF PATIENTS WITH GASTRIC CANCER AFTER RADICAL SURGERY</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Dumanskyi, Yu V ; Kirkilevskyi, S I ; Sulaeva, O M ; Polyasnyi, V O ; Mashukov, A O ; Kovalevska, L A ; Yarema, R R ; Ogorchak, M A</creator><creatorcontrib>Dumanskyi, Yu V ; Kirkilevskyi, S I ; Sulaeva, O M ; Polyasnyi, V O ; Mashukov, A O ; Kovalevska, L A ; Yarema, R R ; Ogorchak, M A</creatorcontrib><description>The strategy for the treatment of gastric cancer (GC), in particular the use of the extended surgical interventions in different countries varies. The different proportion of specific molecular GC subtypes in various populations frequently is not taken into account for comparing treatment outcomes. This pilot study analyzes the association of survival of GC patients after the extended combined surgical interventions depending on the molecular subtype of the tumors. An improved survival for patients with diffuse cancer types (p53-, VEGFR
, HER2/neu
, Ki-67
phenotype) was demonstrated. The authors propose their point of view on the importance of recognizing GC molecular heterogeneity.Key Words: gastric cancer, molecular classification, tumor biology.</description><identifier>ISSN: 1812-9269</identifier><identifier>EISSN: 2312-8852</identifier><identifier>DOI: 10.32471/exp-oncology.2312-8852.vol-44-no-4.18903</identifier><identifier>PMID: 36811544</identifier><language>eng</language><publisher>Ukraine</publisher><subject>Humans ; Phenotype ; Pilot Projects ; Prognosis ; Receptor, ErbB-2 - genetics ; Stomach Neoplasms ; Treatment Outcome</subject><ispartof>Experimental oncology, 2022-12, Vol.44 (4), p.324-326</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36811544$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dumanskyi, Yu V</creatorcontrib><creatorcontrib>Kirkilevskyi, S I</creatorcontrib><creatorcontrib>Sulaeva, O M</creatorcontrib><creatorcontrib>Polyasnyi, V O</creatorcontrib><creatorcontrib>Mashukov, A O</creatorcontrib><creatorcontrib>Kovalevska, L A</creatorcontrib><creatorcontrib>Yarema, R R</creatorcontrib><creatorcontrib>Ogorchak, M A</creatorcontrib><title>IMPACT OF TUMOR MOLECULAR PHENOTYPE ON SURVIVAL OF PATIENTS WITH GASTRIC CANCER AFTER RADICAL SURGERY</title><title>Experimental oncology</title><addtitle>Exp Oncol</addtitle><description>The strategy for the treatment of gastric cancer (GC), in particular the use of the extended surgical interventions in different countries varies. The different proportion of specific molecular GC subtypes in various populations frequently is not taken into account for comparing treatment outcomes. This pilot study analyzes the association of survival of GC patients after the extended combined surgical interventions depending on the molecular subtype of the tumors. An improved survival for patients with diffuse cancer types (p53-, VEGFR
, HER2/neu
, Ki-67
phenotype) was demonstrated. The authors propose their point of view on the importance of recognizing GC molecular heterogeneity.Key Words: gastric cancer, molecular classification, tumor biology.</description><subject>Humans</subject><subject>Phenotype</subject><subject>Pilot Projects</subject><subject>Prognosis</subject><subject>Receptor, ErbB-2 - genetics</subject><subject>Stomach Neoplasms</subject><subject>Treatment Outcome</subject><issn>1812-9269</issn><issn>2312-8852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kNtOwkAQhjdGI4i-gtlLb4q73VP3sqkFmgAlZcFwtelhazCFxVaMvr3leDMzyXzzT_IBgDHqE5cK_Gp-d47d5rayH399l2DX8Tzm9n9s5VDqbK1D-9iTiNyA7nV7C7rYa2fpctkBD03ziRBnktN70CHcw5hR2gUmmsz8QMF4ANViEidwEo_DYDH2EzgbhdNYrWYhjKdwvkiW0dIfH8CZr6JwqubwPVIjOPTnKokCGPjTIEygP1BtTfy3KGjp9mwYJqtHcFemVWOezr0HFoNQBSNnHA8PnJNj6X47BnHKBBY0LVlBTO6lgkuUujwj3GQUiUyUZSEKhjnmBcZEpghJkqU5YrlkgvTAyyl3V9uvvWm-9Wbd5Kaq0q2x-0a7QkjCkEdQi0YnNK9t09Sm1Lt6vUnrP42RPlrXrXV9sa4PXvXBq26ta0r11mqqj9bbrOfz2322McU16aKZ_ANR530s</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Dumanskyi, Yu V</creator><creator>Kirkilevskyi, S I</creator><creator>Sulaeva, O M</creator><creator>Polyasnyi, V O</creator><creator>Mashukov, A O</creator><creator>Kovalevska, L A</creator><creator>Yarema, R R</creator><creator>Ogorchak, M A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202212</creationdate><title>IMPACT OF TUMOR MOLECULAR PHENOTYPE ON SURVIVAL OF PATIENTS WITH GASTRIC CANCER AFTER RADICAL SURGERY</title><author>Dumanskyi, Yu V ; Kirkilevskyi, S I ; Sulaeva, O M ; Polyasnyi, V O ; Mashukov, A O ; Kovalevska, L A ; Yarema, R R ; Ogorchak, M A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c192t-e06457174af5d3ec8a7690a26b36eb407b7ffd7d51616d1139a0093bac05c9573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Humans</topic><topic>Phenotype</topic><topic>Pilot Projects</topic><topic>Prognosis</topic><topic>Receptor, ErbB-2 - genetics</topic><topic>Stomach Neoplasms</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dumanskyi, Yu V</creatorcontrib><creatorcontrib>Kirkilevskyi, S I</creatorcontrib><creatorcontrib>Sulaeva, O M</creatorcontrib><creatorcontrib>Polyasnyi, V O</creatorcontrib><creatorcontrib>Mashukov, A O</creatorcontrib><creatorcontrib>Kovalevska, L A</creatorcontrib><creatorcontrib>Yarema, R R</creatorcontrib><creatorcontrib>Ogorchak, M A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dumanskyi, Yu V</au><au>Kirkilevskyi, S I</au><au>Sulaeva, O M</au><au>Polyasnyi, V O</au><au>Mashukov, A O</au><au>Kovalevska, L A</au><au>Yarema, R R</au><au>Ogorchak, M A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IMPACT OF TUMOR MOLECULAR PHENOTYPE ON SURVIVAL OF PATIENTS WITH GASTRIC CANCER AFTER RADICAL SURGERY</atitle><jtitle>Experimental oncology</jtitle><addtitle>Exp Oncol</addtitle><date>2022-12</date><risdate>2022</risdate><volume>44</volume><issue>4</issue><spage>324</spage><epage>326</epage><pages>324-326</pages><issn>1812-9269</issn><eissn>2312-8852</eissn><abstract>The strategy for the treatment of gastric cancer (GC), in particular the use of the extended surgical interventions in different countries varies. The different proportion of specific molecular GC subtypes in various populations frequently is not taken into account for comparing treatment outcomes. This pilot study analyzes the association of survival of GC patients after the extended combined surgical interventions depending on the molecular subtype of the tumors. An improved survival for patients with diffuse cancer types (p53-, VEGFR
, HER2/neu
, Ki-67
phenotype) was demonstrated. The authors propose their point of view on the importance of recognizing GC molecular heterogeneity.Key Words: gastric cancer, molecular classification, tumor biology.</abstract><cop>Ukraine</cop><pmid>36811544</pmid><doi>10.32471/exp-oncology.2312-8852.vol-44-no-4.18903</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1812-9269 |
| ispartof | Experimental oncology, 2022-12, Vol.44 (4), p.324-326 |
| issn | 1812-9269 2312-8852 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2779350830 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Humans Phenotype Pilot Projects Prognosis Receptor, ErbB-2 - genetics Stomach Neoplasms Treatment Outcome |
| title | IMPACT OF TUMOR MOLECULAR PHENOTYPE ON SURVIVAL OF PATIENTS WITH GASTRIC CANCER AFTER RADICAL SURGERY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A37%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IMPACT%20OF%20TUMOR%20MOLECULAR%20PHENOTYPE%20ON%20SURVIVAL%20OF%20PATIENTS%20WITH%20GASTRIC%20CANCER%20AFTER%20RADICAL%20SURGERY&rft.jtitle=Experimental%20oncology&rft.au=Dumanskyi,%20Yu%20V&rft.date=2022-12&rft.volume=44&rft.issue=4&rft.spage=324&rft.epage=326&rft.pages=324-326&rft.issn=1812-9269&rft.eissn=2312-8852&rft_id=info:doi/10.32471/exp-oncology.2312-8852.vol-44-no-4.18903&rft_dat=%3Cproquest_cross%3E2779350830%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2779350830&rft_id=info:pmid/36811544&rfr_iscdi=true |